Technology

Three core technologies which have multiple applications and are exclusively in-licensed to Bone by Mozaic Discovery Ltd, Axcess Ltd and Vaxcine Ltd for the therapeutic area, form the basis of the Company's proposals for the future, namely:

1. Three patents/applications on oral peptide drug delivery system ("Axcess");
2. Stem cell / drug discovery system ("Mozaic"); and
3. Oral vaccination/tolerisation systems and patent/application ("Vaxcine").

Bone has exclusive global licences for present and future applications of technologies that derive from Axcess, Vaxcine and Mozaic discoveries for the field of musculo-skeletal therapies.

View Technical
Information Brochure
(large file size)